375 related articles for article (PubMed ID: 31492174)
41. NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.
Dickson BC; Sung YS; Rosenblum MK; Reuter VE; Harb M; Wunder JS; Swanson D; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):636-645. PubMed ID: 29356724
[TBL] [Abstract][Full Text] [Related]
42. NUT midline carcinoma: an imaging case series and review of literature.
Polsani A; Braithwaite KA; Alazraki AL; Abramowsky C; Shehata BM
Pediatr Radiol; 2012 Feb; 42(2):205-10. PubMed ID: 22033856
[TBL] [Abstract][Full Text] [Related]
43. BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings.
Nelson BA; Lee EY; French CA; Bauer DE; Vargas SO
J Thorac Imaging; 2010 Aug; 25(3):W93-6. PubMed ID: 20395873
[TBL] [Abstract][Full Text] [Related]
44. NUT midline lung cancer: a rare case report with literature review.
Gupta R; Mumaw D; Antonios B; Anusim N; Dhulipalla SP; Stender M; Huben M; Jaiyesimi I
AME Case Rep; 2022; 6():2. PubMed ID: 35128310
[TBL] [Abstract][Full Text] [Related]
45. Salivary Gland NUT Carcinoma with Prolonged Survival in Children: Case Illustration and Systematic Review of Literature.
Wang H; Weiss VL; Hoffman RD; Abel T; Ho RH; Borinstein SC; Mannion K; Bridge JA; Black J; Liang J
Head Neck Pathol; 2021 Mar; 15(1):236-243. PubMed ID: 32077054
[TBL] [Abstract][Full Text] [Related]
46. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.
French CA; Rahman S; Walsh EM; Kühnle S; Grayson AR; Lemieux ME; Grunfeld N; Rubin BP; Antonescu CR; Zhang S; Venkatramani R; Dal Cin P; Howley PM
Cancer Discov; 2014 Aug; 4(8):928-41. PubMed ID: 24875858
[TBL] [Abstract][Full Text] [Related]
47. Nuclear protein of the testis midline carcinoma in the oral cavity: retrospective review of those initially diagnosed as poorly differentiated squamous cell carcinoma using an anti-C52B1 antibody.
Aizawa H; Yamada S; Sakai H; Otakiri H; Akita D; Gibo T; Kurita H
Int J Oral Maxillofac Surg; 2019 Oct; 48(10):1265-1272. PubMed ID: 30876795
[TBL] [Abstract][Full Text] [Related]
48. P63-negative pulmonary NUT carcinoma arising in the elderly: a case report.
Numakura S; Saito K; Motoi N; Mori T; Saito Y; Yokote F; Kanamoto Y; Asami M; Sakai T; Yamauchi Y; Sakao Y; Uozaki H; Kawamura M
Diagn Pathol; 2020 Nov; 15(1):134. PubMed ID: 33176817
[TBL] [Abstract][Full Text] [Related]
49. A case of endobronchial NUT midline carcinoma with intraluminal growth.
Watanabe S; Hirano S; Mine S; Yoshida A; Motoi T; Ishii S; Naka G; Takeda Y; Igari T; Sugiyama H; Kobayashi N
Anticancer Res; 2015 Mar; 35(3):1607-12. PubMed ID: 25750317
[TBL] [Abstract][Full Text] [Related]
50. Midline carcinoma of children and young adults with NUT rearrangement.
French CA; Kutok JL; Faquin WC; Toretsky JA; Antonescu CR; Griffin CA; Nose V; Vargas SO; Moschovi M; Tzortzatou-Stathopoulou F; Miyoshi I; Perez-Atayde AR; Aster JC; Fletcher JA
J Clin Oncol; 2004 Oct; 22(20):4135-9. PubMed ID: 15483023
[TBL] [Abstract][Full Text] [Related]
51. NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.
Agaimy A; Fonseca I; Martins C; Thway K; Barrette R; Harrington KJ; Hartmann A; French CA; Fisher C
Am J Surg Pathol; 2018 Jul; 42(7):877-884. PubMed ID: 29649019
[TBL] [Abstract][Full Text] [Related]
52. Case report of a pan-cytokeratin negative NUT midline carcinoma of pulmonary origin, a BRD3-NUT variant: Challenges in cytomorphologic presentation.
Hwang J; Marinelli L; Chormanski D; Rose H; Williams G; Adams T; Van Dellen M
Diagn Cytopathol; 2023 Jul; 51(7):E209-E213. PubMed ID: 37021735
[TBL] [Abstract][Full Text] [Related]
53. The importance of diagnosing NUT midline carcinoma.
French CA
Head Neck Pathol; 2013 Mar; 7(1):11-6. PubMed ID: 23463074
[TBL] [Abstract][Full Text] [Related]
54. NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primary.
Shehata BM; Steelman CK; Abramowsky CR; Olson TA; French CA; Saxe DF; Ricketts RR; Katzenstein HM
Pediatr Dev Pathol; 2010; 13(6):481-5. PubMed ID: 20017639
[TBL] [Abstract][Full Text] [Related]
55. NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum.
Stevens TM; Morlote D; Xiu J; Swensen J; Brandwein-Weber M; Miettinen MM; Gatalica Z; Bridge JA
Mod Pathol; 2019 Jun; 32(6):764-773. PubMed ID: 30723300
[TBL] [Abstract][Full Text] [Related]
56. Pathogenesis of NUT midline carcinoma.
French CA
Annu Rev Pathol; 2012; 7():247-65. PubMed ID: 22017582
[TBL] [Abstract][Full Text] [Related]
57. NUT carcinoma of the lung.
Lantuejoul S; Pissaloux D; Ferretti GR; McLeer A
Semin Diagn Pathol; 2021 Sep; 38(5):72-82. PubMed ID: 34176698
[TBL] [Abstract][Full Text] [Related]
58. Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.
Agaimy A; Haller F; Renner A; Niedermeyer J; Hartmann A; French CA
Am J Surg Pathol; 2022 Feb; 46(2):281-288. PubMed ID: 34232599
[TBL] [Abstract][Full Text] [Related]
59. NUT midline carcinomas of the sinonasal tract.
Bishop JA; Westra WH
Am J Surg Pathol; 2012 Aug; 36(8):1216-21. PubMed ID: 22534723
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.
Haack H; Johnson LA; Fry CJ; Crosby K; Polakiewicz RD; Stelow EB; Hong SM; Schwartz BE; Cameron MJ; Rubin MA; Chang MC; Aster JC; French CA
Am J Surg Pathol; 2009 Jul; 33(7):984-91. PubMed ID: 19363441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
